Altamura, C, Scrascia, F, Quattrocchi, CC, Errante, Y, Gangemi, E, Curcio, G, Ursini, F, Silvestrini, M, Maggio, P, Beomonte Zobel, B, Rossini, PM, Pasqualetti, P, Falsetti, L, Vernieri, F (2016). Regional MRI diffusion, white-matter hyperintensities, and cognitive function in Alzheimer’s disease and vascular dementia. J Clin Neurol 12(2):201–208CrossRefGoogle ScholarPubMed

Banerjee, G, Carare, R, Cordonnier, C, Greenberg, SM, Schneider, JA, Smith, EE, Buchem, MV, Grond, JV, Verbeek, MM, Werring, DJ (2017). The increasing impact of cerebral amyloid angiopathy: Essential new insights for clinical practice. J Neurol Neurosurg Psychiatry 88(11):982–994Google Scholar

Barber, R, Scheltens, P, Gholkar, A et al. (1999). White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer’s disease, vascular dementia, and normal aging. Journal of Neurology, Neurosurgery and Psychiatry 67:66–72Google Scholar

Bastos-Leite, AJ, van der Flier, WM, van Straaten, EC et al. (2007). The contribution of medial temporal lobe atrophy and vascular pathology to cognitive impairment in vascular dementia. Stroke 38:3182–3185CrossRefGoogle ScholarPubMed

Bath, PM, Scutt, P, Blackburn, DJ et al. PODCAST Trial Investigators. (2017). Intensive versus guideline blood pressure and lipid lowering in patients with previous stroke: Main results from the pilot “Prevention of Decline in Cognition after Stroke Trial” (PODCAST) randomised controlled trial. PLoS One 12(1):e0164608CrossRefGoogle Scholar

Bernick, C, Katz, R, Smith, NL et al. (2005). Statins and cognitive function in the elderly: The Cardiovascular Health Study. Neurology 65:1388–1394CrossRefGoogle ScholarPubMed

Black, S, Roman, GC, Geldmacher, DS et al. (2003). Efficacy and tolerability of donepezil in vascular dementia: Positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial. Stroke 34:2323–2330Google Scholar

Charidimou, A, Werring, DJ (2012). Cerebral microbleeds and cognition in cerebrovascular disease: An update. J Neurol Sci 322(1–2):50–55Google Scholar

Charlton, RA, Barrick, TR, McIntyre, DJ et al. (2006). White matter damage on diffusion tensor imaging correlates with age-related cognitive decline. Neurology 66:217–222Google Scholar

Chen, A, Akinyemi, RO, Hase, Y, Firbank, MJ, Ndung’u, MN, Foster, V, Craggs, LJ, Washida, K, Okamoto, Y, Thomas, AJ, Polvikoski, TM, Allan, LM, Oakley, AE, O’Brien, JT, Horsburgh, K, Ihara, M, Kalaria, RN (2016). Frontal white matter hyperintensities, clasmatodendrosis and gliovascular abnormalities in ageing and post-stroke dementia. Brain 139(1):242–258CrossRefGoogle ScholarPubMed

Cordoliani-Mackowiak, M, Hénon, H, Pruvo, J et al. (2003). Post stroke dementia: Influence of hippocampal atrophy. Archives of Neurology 60:585–590CrossRefGoogle Scholar

Cummings, JL (1993). Frontal-subcortical circuits and human behavior. Archives of Neurology 50:873–880Google Scholar

Delano-Wood, L, Abeles, N, Sacco, JM et al. (2008). Regional white matter pathology in mild cognitive impairment: Differential influence of lesion type on neuropsychological functioning. Stroke 39:794–799Google Scholar

de Leon, MJ, Golomb, J, George, AE et al. (1993). The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation. American Journal of Neuroradiology 14:897–906Google ScholarPubMed

Diniz, BS, Butters, MA, Albert, SM, Dew, MA, Reynolds, CF III (2013). Late-life depression and risk of vascular dementia and Alzheimer’s disease: Systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry 202:329–335Google Scholar

Erkinjuntti, T, Kurz, A, Gauthier, S et al. (2002). Efficacy of galanthamine in probable vascular dementia and Alzheimer’s disease combined with cerebrovascular disease: A randomised trial. Lancet 359:1283–1290Google Scholar

Feigin, V, Ratnasabapathy, Y, Anderson, C (2005). Does blood pressure lowering treatment prevent dementia or cognitive decline in patients with cardiovascular and cerebrovascular disease? Journal of Neurology Science 15:151–155Google Scholar

Fein, G, Di Sclafani, V, Tanabe, J et al. (2000). Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology 55:1626–1635Google Scholar

Firbank, MJ, Burton, EJ, Barber, R et al. (2007). Medial temporal atrophy rather than white matter hyperintensities predict cognitive decline in stroke survivors. Neurobiology Aging 28:1664–1669Google Scholar

Frisoni, GB, Galluzzi, S, Pantoni, L et al. (2007). The effect of white matter lesions on cognition in the elderly – small but detectable. Nature Clinical and Practical Neurology 3:620–627Google Scholar

Guekht, A, Skoog, I, Edmundson, S, Zakharov, V, Korczyn, AD (2017). ARTEMIDA trial (a randomized trial of efficacy, 12 months international double-blind actovegin): A randomized controlled trial to assess the efficacy of actovegin in poststroke cognitive impairment. Stroke 48:1262–1270Google Scholar

Grau-Olivares, M, Bartrés-Faz, D, Arboix, A et al. (2007). Mild cognitive impairment after lacunar infarction: Voxel-based morphometry and neuropsychological assessment. Cerebrovascular Diseases 23:353–361Google Scholar

Heart Protection Study Collaborative Group (2002). MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: A randomised placebo-controlled trial. Lancet 360:7–22Google Scholar

Ihle-Hansen, H, Thommessen, B, Fagerland, MW, Øksengård, AR, Wyller, TB, Engedal, K, Fure, B (2014). Multifactorial vascular risk factor intervention to prevent cognitive impairment after stroke and TIA: A 12-month randomized controlled trial. Int J Stroke 9(7):932–938Google Scholar

Jagust, WJ, Zheng, L, Harvey, DJ (2008). Neuropathological basis of magnetic resonance images in aging and dementia. Annals of Neurology 63:72–82Google Scholar

Jobst, KA, Smith, AD, Szatmari, M et al. (1992). Detection in life of confirmed Alzheimer’s disease using a simple measurement of medial temporal lobe atrophy by computed tomography. Lancet 340:1179–1183Google Scholar

Jobst, KA, Barnetson, LP, Shepstone, BJ (1998). Accurate prediction of histologically confirmed Alzheimer’s disease and the differential diagnosis of dementia: The use of NINCDS–ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and Apo E4 in medial temporal lobe dementias. Oxford Project to Investigate Memory and Aging. International Psychogeriatrics 10:271–302Google Scholar

Jokinen, H, Gonçalves, N, Vigário, R, Lipsanen, J, Fazekas, F, Schmidt, R, Barkhof, F, Madureira, S, Verdelho, A, Inzitari, D, Pantoni, L, Erkinjuntti, T (2015). LADIS Study Group. Early-stage white matter lesions detected by multispectral MRI segmentation predict progressive cognitive decline. Front Neurosci 2(9):455Google Scholar

Jouvent, E, Viswanathan, A, Mangin, JF et al. (2007). Brain atrophy is related to lacunar lesions and tissue microstructural changes in CADASIL. Stroke 38:1786–1790CrossRefGoogle ScholarPubMed

Kalaria, RN, Ihara, M (2017). Medial temporal lobe atrophy is the norm in cerebrovascular dementias. Eur J Neurol 24(4):539–540Google Scholar

Kim, HJ, Im, K, Kwon, H, Lee, JM, Kim, C, Kim, YJ, Jung, NY, Cho, H, Ye, BS, Noh, Y, Kim, GH, Ko, ED, Kim, JS, Choe, YS, Lee, KH, Kim, ST, Lee, JH, Ewers, M, Weiner, MW, Na, DL, Seo, SW (2015a). Clinical effect of white matter network disruption related to amyloid and small vessel disease. Neurology 85(1):63–70Google Scholar

Kim, HJ, Im, K, Kwon, H, Lee, JM, Ye, BS, Kim, YJ, Cho, H, Choe, YS, Lee, KH, Kim, ST, Kim, JS, Lee, JH, Na, DL, Seo, SW (2015b). Effects of amyloid and small vessel disease on white matter network disruption. J Alzheimers Dis 44(3):963–975Google Scholar

Konishi, J, Yamada, K, Kizu, O et al. (2005). MR tractography for the evaluation of functional recovery from lenticulostriate infarcts. Neurology 64:108–113CrossRefGoogle ScholarPubMed

Laakso, MP, Partanen, K, Riekkinen, P et al. (1996). Hippocampal volumes in Alzheimer’s disease, Parkinson’s disease with and without dementia, and in vascular dementia: An MRI study. Neurology 46:678–681CrossRefGoogle ScholarPubMed

Leys, D, Hénon, H, Pasquier, F (1998). White matter changes and poststroke dementia. Dement Geriatr Cogn Disord 9(1):25–29Google Scholar

Liang, Y, Sun, X, Xu, S, Liu, Y, Huang, R, Jia, J, Zhang, Z (2016). Preclinical Cerebral Network connectivity evidence of deficits in mild white matter lesions. Front Aging Neurosci 18(8):27Google Scholar

Libon, DJ, Price, CC, Giovannetti, T et al. (2008). Linking MRI hyperintensities with patterns of neuropsychological impairment: Evidence for a threshold effect. Stroke 39:806–813Google Scholar

Liu-Ambrose, T, Best, JR, Davis, JC et al. (2016). Aerobic exercise and vascular cognitive impairment: A randomized controlled trial. Neurology 87:2082-2090.CrossRefGoogle ScholarPubMed

Matthews, FE et al. (2013). A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: Results of the Cognitive Function and Ageing Study I and II. Lancet 382:1405–1412Google Scholar

Matthews, FE et al. (2016). A two decade dementia incidence comparison from the Cognitive Function and Ageing Studies I and II. Nat Commun 7:11398Google Scholar

Matz, K, Teuschl, Y, Firlinger, B, Dachenhausen, A, Keindl, M, Seyfang, L, Tuomilehto, J, Brainin, M, ASPIS Study Group (2015). Multidomain lifestyle interventions for the prevention of cognitive decline after ischemic stroke: Randomized trial. Stroke 46(10):2874–2880Google Scholar

Meyer, JS, Rogers, RL, McClintic, K et al. (1989). Randomized clinical trial of daily aspirin therapy in multi-infarct dementia. A pilot study. Journal of the American Geriatric Society 37:549–555Google Scholar

Mok, V, Wong, A, Tang, WK et al. (2005). Determinants of post stroke cognitive impairment in small vessel disease. Dementia and Geriatric Cognitive Disorders 20:225–230Google Scholar

Mungas, D, Jagust, WJ, Reed, BR et al. (2001). MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer’s disease. Neurology 57:2229–2235CrossRefGoogle ScholarPubMed

Ngandu, T, Lehtisalo, J, Solomon, A et al. (2015). A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): A randomised controlled trial. Lancet 385(9984):2255–2263Google Scholar

O’Brien, JT, Metcalfe, S, Swann, A (2000). Medial temporal lobe width on CT scanning in Alzheimer’s disease: Comparison with vascular dementia, depression and dementia with Lewy bodies. Dementia and Geriatric Cognitive Disorders 11:114–118CrossRefGoogle Scholar

Orgogozo, JM, Rigaud, AS, Stoffler, A et al. (2002). Efficacy and safety of memantine in patients with mild to moderate vascular dementia: A randomized, placebo-controlled trial (MMM 300). Stroke 33:1834–1839Google Scholar

O’Sullivan, M, Summers, PE, Jones, DK et al. (2001). Normal-appearing white matter in ischemic leukoaraiosis: A diffusion tensor MRI study. Neurology 57:2307–2310Google Scholar

O’Sullivan, M, Morris, RG, Huckstep, B et al. (2004). Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis. Journal of Neurology, Neurosurgery and Psychiatry 75:441–447Google Scholar

O’Sullivan, M, Barrick, TR, Morris, RG et al. (2005). Damage within a network of white matter regions underlies executive dysfunction in CADASIL. Neurology 65:1584–1590Google Scholar

Pantoni, L, Fierini, F, Poggesi, A (2015). LADIS Study Group. Impact of cerebral white matter changes on functionality in older adults: An overview of the LADIS Study results and future directions. Geriatr Gerontol Int. 15(1):10–16Google Scholar

Pendlebury, ST, Blamire, AM, Lee, MA et al. (1999). Axonal injury in the internal capsule correlates with motor impairment after stroke. Stroke 30:956–962Google Scholar

Pendlebury, ST and Rothwell, PM (2009). Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and met-analysis. Lancet Neurology 8:1006–1018Google Scholar

Pendlebury, ST, Wharton, RM, Rothwell, PM (2017a). Predictors of dementia after TIA/stroke: 15-year population-based follow-up study. J Eur Stroke 2(suppl 1):AS11–003Google Scholar

Pineiro, R, Pendlebury, ST, Smith, S et al. (2000). Relating MRI changes to motor deficit after ischemic stroke by segmentation of functional motor pathways. Stroke 31:672–679Google Scholar

Prins, ND, van Dijk, EJ, den Heijer, T et al. (2005). Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain 128:2034–2041Google Scholar

PROGRESS Collaborative Group (2001). Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 358:1033–1041CrossRefGoogle Scholar

Ritchie, C, Smailagic, N, Noel-Storr, AH, Ukoumunne, O, Ladds, EC, Martin, S (2017). CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 3:CD010803Google Scholar

Roman, GC, Tatemichi, TK, Erkinjuntti, T et al. (1993). Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS–AIREN International Workshop. Neurology 43:250–260CrossRefGoogle ScholarPubMed

Sachdev, P, Kalaria, R, O’Brien, J et al. (2014). International Society for Vascular Behavioral and Cognitive Disorders. Diagnostic criteria for vascular cognitive disorders: A VASCOG statement. Alzheimer Dis Assoc Disord. 28(3):206–218CrossRefGoogle ScholarPubMed

Sheline, YI, Pieper, CF, Barch, DM, Welsh-Bohmer, K, McKinstry, RC, MacFall, JR, D’Angelo, G, Garcia, KS, Gersing, K, Wilkins, C et al. (2010). Support for the vascular depression hypothesis in late-life depression: Results of a 2-site, prospective, antidepressant treatment trial. Arch Gen Psychiatry 67:277–285Google Scholar

Shepherd, J, Blauw, GJ, Murphy, MB et al. (2002). PROspective Study of Pravastatin in the Elderly at Risk. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomised controlled trial. Lancet 360:1623–1630Google Scholar

Smith, CD, Snowdon, DA, Wang, H et al. (2000). White matter volumes and periventricular white matter hyperintensities in aging and dementia. Neurology 54:838–842Google Scholar

Stebbins, GT, Nyenhuis, DL, Wang, C et al. (2008). Gray matter atrophy in patients with ischemic stroke with cognitive impairment. Stroke 39:785–793Google Scholar

Swartz, RH, Stuss, DT, Gao, F et al. (2008). Independent cognitive effects of atrophy, diffuse subcortical and thalamo-cortical cerebrovascular disease in dementia. Stroke 39:822–830Google Scholar

Taylor, WD, Bae, JN, MacFall, JR et al. (2007). Widespread effects of hyperintense lesions on cerebral white matter structure. American Journal of Roentgenology 188:1695–1704Google Scholar

Tekin, S, Cummings, JL (2002). Frontal-subcortical neuronal circuits and clinical neuropsychiatry: An update. Journal of Psychosomatic Research 53:647–654Google Scholar

Tuladhar, AM, van Uden, IW, Rutten-Jacobs, LC, Lawrence, A, van der Holst, H, van Norden, A, de Laat, K, van Dijk, E, Claassen, JA, Kessels, RP, Markus, HS, Norris, DG, de Leeuw, FE (2016). Structural network efficiency predicts conversion to dementia. Neurology. 86(12):1112–1119Google Scholar

Varley, J, Taylor, J, Irani, SR (2017). Autoantibody-mediated diseases of the CNS: Structure, dysfunction and therapy. Neuropharmacology. May 3. pii: S0028-3908(17)30196–XGoogle Scholar

Vermeer, SE, Longstreth, WT Jr., Koudstaal, PJ (2007). Silent brain infarcts: A systematic review. Lancet Neurology 6:611–619Google Scholar

Wardlaw, JM, Smith, EE, Biessels, GJ et al. (2013). STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1). Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 12(8):822–838Google Scholar

Wilcock, G, Mobius, HJ, Stoffler, A et al. (2002). A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500). International Clinical Psychopharmacology 17:297–305Google Scholar

Wilkinson, D, Doody, R, Helme, R et al. (2003). Donepezil in vascular dementia: A randomized placebo-controlled study. Neurology 61:479–486Google Scholar

Won Seo, S, Hwa Lee, B, Kim, EJ et al. (2007). Clinical significance of microbleeds in subcortical vascular dementia. Stroke 38:1949–1951Google Scholar

Wright, CB, Festa, JR, Paik, MC et al. (2008). White matter hyperintensities and subclinical infarction: Associations with psychomotor speed and cognitive flexibility. Stroke 39:800–805Google Scholar

Xu, Q, Zhou, Y, Li, YS, Cao, WW, Lin, Y, Pan, YM, Chen, SD (2010). Diffusion tensor imaging changes correlate with cognition better than conventional MRI findings in patients with subcortical ischemic vascular disease. Dement Geriatr Cogn Disord. 30(4):317–326Google Scholar